erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Endocarditis, Bacterial D004697 5 associated lipids
Endocarditis, Subacute Bacterial D004698 1 associated lipids
Endometritis D004716 6 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Epidermitis, Exudative, of Swine D004818 1 associated lipids
Epilepsy D004827 35 associated lipids
Ergotism D004881 4 associated lipids
Erysipelas D004886 1 associated lipids
Erythema Multiforme D004892 3 associated lipids
Erythema Nodosum D004893 5 associated lipids
Erythrasma D004894 1 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Esophagitis, Peptic D004942 4 associated lipids
Eye Diseases D005128 12 associated lipids
Factor X Deficiency D005171 2 associated lipids
Fecal Incontinence D005242 1 associated lipids
Femoral Fractures D005264 7 associated lipids
Fetal Membranes, Premature Rupture D005322 4 associated lipids
Fever D005334 35 associated lipids
Fever of Unknown Origin D005335 3 associated lipids
Focal Infection, Dental D005491 1 associated lipids
Folliculitis D005499 7 associated lipids
Food Hypersensitivity D005512 7 associated lipids
Foot Diseases D005534 4 associated lipids
Fractures, Open D005597 3 associated lipids
Furunculosis D005667 2 associated lipids
Gangrene D005734 3 associated lipids
Gardner Syndrome D005736 2 associated lipids
Gas Gangrene D005738 1 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Tourette Syndrome D005879 3 associated lipids
Glomerulonephritis D005921 35 associated lipids
Gonorrhea D006069 7 associated lipids
Granuloma Inguinale D006100 2 associated lipids
Granuloma, Lethal Midline D006103 2 associated lipids
Haemophilus Infections D006192 3 associated lipids
Hand Dermatoses D006229 5 associated lipids
Hearing Disorders D006311 10 associated lipids
Hearing Loss, Conductive D006314 2 associated lipids
Hearing Loss, Functional D006315 2 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Heart Block D006327 3 associated lipids
Heart Diseases D006331 8 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Failure D006333 36 associated lipids
Heart Murmurs D006337 1 associated lipids
Hematemesis D006396 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Xu J et al. [Prognosticating the region-selectivity in the O-methylation reaction of erythromycins by conformational search model]. 2003 Yao Xue Xue Bao pmid:12778744
Xu P et al. [Synthesis of derivatives of (9S) -9-hydroxyl-12-methylene erythromycin A and their antibacterial activity in vitro]. 2007 Yao Xue Xue Bao pmid:17703771
Sun W et al. [Glycosyl isomerization based on the biosynthesis of natural-product sugar from microorganism]. 2013 Yao Xue Xue Bao pmid:23672013
Chen SX et al. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives]. 2001 Yao Xue Xue Bao pmid:12579933
Marmiroli N and Bilinski CA Partial restoration of meiosis in an apomictic strain of Saccharomyces cerevisiae: a model system for investigation of nucleomitochondrial interactions during sporulation. 1985 Yeast pmid:3916858
Goffrini P et al. RAG1 and RAG2: nuclear genes involved in the dependence/independence on mitochondrial respiratory function for growth on sugars. 1989 Mar-Apr Yeast pmid:2711752
Uh Y et al. Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. 2005 Yonsei Med. J. pmid:16127771
Hatipoglu ON and Tasan Y A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia. 2000 Yonsei Med. J. pmid:10957888
Uh Y et al. Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital. 2007 Yonsei Med. J. pmid:17963333
Kim HY and Uh Y Macrolide resistance in beta-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea. 2004 Yonsei Med. J. pmid:15344198
Heite HJ [Therapy of venereal infections]. 1971 Z Allgemeinmed pmid:5108596
Ocklitz HW et al. [Pediatric guidelines. 3. Antibiotics--indications]. 1968 Z Arztl Fortbild (Jena) pmid:4978334
Dietzsch HJ et al. [Abscessed (staphylococcal) pneumonia in childhood]. 1972 Z Arztl Fortbild (Jena) pmid:4118084
Handrick W et al. [Contribution to the diagnosis and therapy of juvenile pneumonia]. 1981 Z Arztl Fortbild (Jena) pmid:7340181
Naumann G [The detection of the agent of Legionnaires' disease--a confirmation of Koch's postulates]. 1983 Z Erkr Atmungsorgane pmid:6356647
Fischer P and Schilling W [Therapeutic results in lung diseases caused by atypical mycobacteria]. 1984 Z Erkr Atmungsorgane pmid:6202070
Kirsten D and Meister W [Present possibilities of antibiotic therapy in chronic non-specific respiratory diseases (author's transl)]. 1976 Z Erkr Atmungsorgane pmid:1049185
Folwaczny C et al. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma]. 1997 Z Gastroenterol pmid:9432812
Wienbeck M and Barnert J [Principles of pharmacotherapy]. 1990 Z Gastroenterol pmid:2162581
Bassotti G et al. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. 1998 Z Gastroenterol pmid:9577904
Schusdziarra V [Motilin and motilides--future perspectives for therapy of gastrointestinal motility disorders]. 1992 Z Gastroenterol pmid:1413940
Griga T et al. [Effect of stomach motility on measuring stomach permeability with saccharose in vivo]. 1999 Z Gastroenterol pmid:10378362
Neubrand M and Sauerbruch T Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid. 1998 Z Gastroenterol pmid:9612923
VON KOBYLETZKI D and STRAUCH [EXPERIMENTAL STUDIES ON THE PROBLEM OF DIAPLACENTAL PASSAGE AND THE EXCRETION OF ERYTHROMYCIN-ESTOLATE (PELS) WITH HUMAN MILK]. 1964 Z Geburtshilfe Gynakol pmid:14198621
Hoppe JE [Whooping cough in pregnant patients and newborn infants]. 1996 Nov-Dec Z Geburtshilfe Neonatol pmid:9081753
Winkler M et al. [Puerperium after threatened premature labor--effects of infection screening in pregnancy]. 1994 Mar-Apr Z Geburtshilfe Perinatol pmid:8023535
Dittmer A [Use of antibiotics--principles and possibilities]. 1984 Z Gesamte Hyg pmid:6324502
Hudemann H [Staphylococci and mycoses as a cause of diarrhea]. 1974 Z Gesamte Inn Med pmid:4617437
Hirschelmann R and Bekemeier H [Anti-inflammatory effects of chemotherapeutics and antibiotics]. 1973 Z Gesamte Inn Med pmid:4779148
Tauchnitz C [Current status of antibiotic therapy]. 1973 Z Gesamte Inn Med pmid:4349582
Gebhart A and Cervený R [Contribution to the problem of staphylococcal enterocolitis]. 1966 Z Gesamte Inn Med pmid:5986532
Peeters TL [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders]. 1991 Z Gesamte Inn Med pmid:1926941
FRICKE G [Results with erycinum in internal diseases]. 1957 Z Gesamte Inn Med pmid:13468608
Tauchnitz C [Expedient therapy of chronic pyelonephritis]. 1970 Z Gesamte Inn Med pmid:4331735
ZINZIUS J [Some side-effects of erythromycin]. 1955 Z Haut Geschlechtskr pmid:13257371
Landes E and Metz B [Syphilis therapy in penicillin incompatibility]. 1970 Z Haut Geschlechtskr pmid:5505299
DORN H [Lymphogranuloma venereum (primary lesion, late stage, treatment with erycinum)]. 1956 Z Haut Geschlechtskr pmid:13353318
WEISE HJ [Experiences with erythromycin in some skin diseases]. 1956 Z Haut Geschlechtskr pmid:13353333
Windorfer A and Mihailova K [Influence of various drugs and pH-values on albumin-bilirubin binding in vitro]. 1973 Z Kinderheilkd pmid:4686270
Mochmann H et al. [The sensitivity of B. pertussis to antibiotics. Examination of 122 patients' strains of B. pertussis]. 1969 Z Kinderheilkd pmid:4315563
Krauer-Mayer B [Antibacterial therapy in the newborn infant]. 1967 Z Kinderheilkd pmid:4297705
Bláhová O and Drastík J [Antibiotics for recurrent acute otitis media in infants under two (author's transl)]. 1973 Z Laryngol Rhinol Otol pmid:4149361
Zierfels G and Petz M [Fluorimetric determination of erythromycin residues in foods of animal origin after derivatization with FMOC and HPLC separation]. 1994 Z Lebensm Unters Forsch pmid:8197827
Pulverer G [Studies with lysotaphin. II. Lysostaphin sensitivity of 230 strains of Staph. aureus of animal origin]. 1968 Z Med Mikrobiol Immunol pmid:5751715
Kayser FH [Effect of benzylpenicillin and ampicillin on enterococci]. 1971 Z Med Mikrobiol Immunol pmid:5554809
Pulverer G [Studies with lysostaphin. I. Lysostaphin sensitivity of 355 strains of Staph. aureus of human origin]. 1968 Z Med Mikrobiol Immunol pmid:5710870
Goldmann SF and Heiss F [The phenomenom of resistance and cross resistance to erythromycin, lincomycin and staphylomycin]. 1971 Z Med Mikrobiol Immunol pmid:4929058
Quincke G [Sensitivity to penicillin of gonococcal strains isolated in Lomé, Togo]. 1970 Z Tropenmed Parasitol pmid:4992455
BALDAMUS U [Antibiotic treatment of unspecific plombage empyema]. 1956 Z Tuberk pmid:13353453
BESZNYAK I et al. [THE ANTIBIOGRAM OF THORACIC EMPYEMA AND ITS LOCAL ANTIBIOTIC THERAPY]. 1964 Z Tuberk Erkr Thoraxorg pmid:14141375
Baumüller A et al. [Bacterial prostatitis--therapeutic principles]. 1977 Z Urol Nephrol pmid:919805
Busch H and Unger K [Studies on pathogen spectra and resistance quotas of infection producing organisms in surgical and urologic diseases in common hospitalization and separate ambulatory settings]. 1975 Z Urol Nephrol pmid:775851
Koopman JP et al. Influence of the antibiotics roxithromycin and erythromycin on the gastro-intestinal ecology of mice. 1987 Z Versuchstierkd pmid:3324551
Malke H Transfer of a plasmid mediating antibiotic resistance between strains of Streptococcus pyogenes in mixed cultures. 1975 Z. Allg. Mikrobiol. pmid:769365
Malke H Interaction of chromosomal mutations to erythromycin resistance with plasmid-mediated resistance to erythromycin and lincomycin in Streptococcus pyogenes. 1977 Z. Allg. Mikrobiol. pmid:337688
Osman HG et al. Utilization of Egyptian raw by-products for the erythromycin production by Streptomyces erythreus. 1968 Z. Allg. Mikrobiol. pmid:4989340
Malke H Transductional analysis of resistance to lincomycin and erythromycin in Streptococcus pyogenes. 1972 Z. Allg. Mikrobiol. pmid:4568554
Riemelt I et al. [Conjugational plasmid transfer from A, B and H streptococci to N streptococci]. 1984 Z. Allg. Mikrobiol. pmid:6441362
Dworsky P [Effect of inhibitors of protein and nucleic acid synthesis on the shape of the nucleoid of Escherichia coli]. 1974 Z. Allg. Mikrobiol. pmid:4142904
Schuhmann E and Taubeneck U [L forms of Escherichia coli K 12 (lambda). I. Induction and mode of multiplication]. 1971 Z. Allg. Mikrobiol. pmid:4107077
Osman HG et al. Factors influencing the biosynthesis of erythromycin by Streptomyces erythreus. 1968 Z. Allg. Mikrobiol. pmid:4916831
Steigleder GK [The effectiveness of neonatal ocular prophylactic treatment for preventing chlamydial or gonococcal conjunctivitis]. 1989 Z. Hautkr. pmid:2741529
Pfannschmidt N et al. [Combined topical treatment of acne with erythromycin and tretinoin]. 1988 Z. Hautkr. pmid:2970158
Rohde BT et al. [Exterior use of erythromycin in acne]. 1978 Z. Hautkr. pmid:152523
Meyer-Rohn J and Puschmann M [Antibacterial effect of an erythromycin-containing topical preparation on the auxanogram test]. 1980 Z. Hautkr. pmid:6447418
Dimitrov K et al. [Clinical etiological findings in chlamydial urethritis in men]. 1984 Z. Hautkr. pmid:6495799
Gerny H [Experiences in dermatologic practice with combined external treatment of acne with benzoyl peroxide and erythromycin]. 1984 Z. Hautkr. pmid:6235684
Rozman TA et al. [Double-blind group comparison of topical meclocycline, erythromycin and placebo in the treatment of papulo-pustulosa acne]. 1984 Z. Hautkr. pmid:6240840
Schmidt JB et al. [Local acne therapy with erythromycin]. 1982 Z. Hautkr. pmid:6461974
Ratzenhofer E et al. [In-vitro inhibition of collagenase activity in epidermolysis bullosa hereditaria dystrophica]. 1978 Z. Hautkr. pmid:216174
Gloor M et al. [Topical treatment of acne vulgaris with erythromycin and benzoylperoxide (author's transl)]. 1982 Z. Hautkr. pmid:6214093
Fanta D [Clinical experiences with a new erythromycin-containing externally administered drug for treatment of acne]. 1980 Z. Hautkr. pmid:6451098
Freitag G et al. [Report of experiences with the clinical trial of a liquid erythromycin-containing topical solution for the treatment of acne]. 1983 Z. Hautkr. pmid:6221475
Schmidt JB et al. [External erythromycin therapy of acne]. 1983 Z. Hautkr. pmid:6229931
Böcker KH [How do I treat acne and rosacea?]. 1986 Z. Hautkr. pmid:2939633
HOFHEINZ W and GRISEBACH H [THE FATTY ACIDS IN STREPTOMYCES ERYTHREUS AND STREPTOMYCES HALSTEDII]. 1965 Z. Naturforsch. B pmid:14287715
Pap H and Grisebach H [Inhibition of erythromycin synthesis in S. erythreus by alph-and beta-fluoropropionic acid]. 1967 Z. Naturforsch. B pmid:4384761
Oehring H et al. [Resistance to chemotherapy of aerobic bacteria from nonspecific odontogenic infections]. 1976 Zahn Mund Kieferheilkd Zentralbl pmid:188271
Rahn R and Knothe H [Antibiotics in dental practice]. 1991 Zahnarztl Mitt pmid:1817410
Takahashi T [Fundamental studies on the usefulness of milk acid bacteria for the human body. II. Experiments on L. acidophilus passage through mice]. 1967 Zasshi Tokyo Ika Daigaku pmid:5626035
SAEVICH NA [Erythromycin and its use in infants with pneumonia]. 1962 Zdravookhr Beloruss pmid:14495964
Schlecht S et al. [Chemical and biological properties of revertants derived from a Salmonella typhimurium Rd1-mutant (author's transl)]. 1980 Zentralbl Bakteriol A pmid:7001806
Gloor M et al. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes). 1981 Zentralbl Bakteriol A pmid:6452774
Dette GA et al. Modifying effects of pH and temperature on (14C)erythromycin uptake into Staphylococcus aureus--relation to antimicrobial activity. 1987 Zentralbl Bakteriol Mikrobiol Hyg A pmid:3673345
Sobetzko R et al. Susceptibility of Ureaplasma urealyticum to ten chemotherapeutic agents. 1988 Zentralbl Bakteriol Mikrobiol Hyg A pmid:2973712
Steere AC et al. Treatment of Lyme disease. 1987 Zentralbl Bakteriol Mikrobiol Hyg A pmid:3109144
Weber K et al. Antibiotic therapy in early erythema migrans disease and related disorders. 1987 Zentralbl Bakteriol Mikrobiol Hyg A pmid:3591091
Wüst J and Hardegger U Studies on the resistance of Clostridium difficile to antimicrobial agents. 1988 Zentralbl Bakteriol Mikrobiol Hyg A pmid:3376619
Haller I and Heinrich S [Actual resistance of Staphylococcus aureus: beta-Lactamase production and susceptibility to various penicillins and erythromycin (author's transl)]. 1982 Zentralbl Bakteriol Mikrobiol Hyg A pmid:6980543
Broughton ES and Flack LE The susceptibility of a strain of Leptospira interrogans serogroup icterohaemorrhagiae to amoxycillin, erythromycin, lincomycin, tetracycline, oxytetracycline and minocycline. 1986 Zentralbl Bakteriol Mikrobiol Hyg A pmid:3765950
Markowitz M Common pitfalls in the management of streptococcal infections. 1970 Zentralbl Bakteriol Orig pmid:4994149
WAGNER V and STEPANOVA J [LACK OF CROSS RESISTANCE TO ERYTHROMYCIN-SPIRAMYCIN IN SOME STAPHYLOCOCCUS PYOGENES STRAINS]. 1963 Zentralbl Bakteriol Orig pmid:14112871
Bredt W et al. [Occurrence of mycoplasmas in pharyngeal swabs]. 1969 Zentralbl Bakteriol Orig pmid:5386764
Schütze E and Gericke D [Experiments on elimination of mycoplasmas from transplantation tumours]. 1969 Zentralbl Bakteriol Orig pmid:5395764
Málek P and Cervinka F [Biological activity of chlortetracycline and of other antibiotics in the damaged muscle]. 1965 Zentralbl Bakteriol Orig pmid:5854512
Banic S and Stropnik Z [Synergistic effect of rifomycin SV and erythromycin]. 1971 Zentralbl Bakteriol Orig pmid:5564121
Schlecht S and Schmidt G [Differentiation of Salmonella R forms by means of antibiotics ant antibacterial dyes]. 1970 Zentralbl Bakteriol Orig pmid:4910455
Grunow R [Studies on the stability of the phage pattern of Shigella sonnei under the influence of antibiotics]. 1965 Zentralbl Bakteriol Orig pmid:5324202
Výmola F et al. [Effect of antibiotics on formation of staphylococcus and Pseudomonas haemolysins]. 1971 Zentralbl Bakteriol Orig A pmid:4400730
Kayser FH and Wüst J [Demonstration of plasmid-specific DNA in staphylococci with multiple resistance]. 1974 Zentralbl Bakteriol Orig A pmid:4154677